Dynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study

Ju-Li Lin,Jian-Xian Lin,Ping Li,Jian-Wei Xie,Jia-bin Wang,Jun Lu,Qi-Yue Chen,Long-long Cao,Chang-Ming Huang,Chao-Hui Zheng
DOI: https://doi.org/10.1186/s12885-019-5993-6
IF: 4.638
2019-09-03
BMC Cancer
Abstract:<h3 class="Heading">Background</h3><p class="Para">This study investigated a large number of patients to develop a predictive nomogram for survival and a web-based survival rate calculator that can dynamically predict the long-term survival of patients with primary gastric diffuse large B-cell lymphoma.</p><h3 class="Heading">Methods</h3><p class="Para">A total of 2647 patients diagnosed with primary gastric diffuse large B-cell lymphoma from 1998 to 2014 were extracted from the SEER database. We used the Lasso Cox regression model to identify independent risk factors for long-term survival and to develop a predictive nomogram for survival and a web-based survival rate calculator.</p><h3 class="Heading">Results</h3><p class="Para">The median (mean) follow-up time was 30 months (52.8 months). Cancer-specific survival rates decreased with time, while the 5-year conditional survival increased with time. Cancer-specific deaths were not constant. Cancer-specific deaths of patients within the first 2 years were high, while the risk remained relatively constant after 2 years. The independent risk factors included surgery, chemotherapy, tumor stage and age, according to the Lasso Cox regression analysis. We developed a predictive nomogram and a web-based survival rate calculator (<span class="ExternalRef"><a href="https://linjuli1991.shinyapps.io/dynnomapp/"><span class="RefSource">https://linjuli1991.shinyapps.io/dynnomapp/</span></a></span>). The calibration plot suggested that the actual value exhibited good agreement with the predicted value.</p><h3 class="Heading">Conclusions</h3><p class="Para">We found that patients with primary gastric diffuse large B-cell lymphoma had a high risk of death during the first 2 years. Additional active follow-up strategies should be provided during this period. This is the first study to develop a predictive nomogram and a web-based survival rate calculator that can provide evidence for individual treatment and follow-up.</p>
oncology
What problem does this paper attempt to address?